未经证实:机器人辅助冠状动脉搭桥术(RCAB)通常不提供给心肺功能降低的高风险患者,严重冠状动脉疾病,和具有挑战性的胸壁解剖。在这项研究中,我们报道了在RCAB期间,对于被认为是常规CAB高危候选人,同时在没有心肺支持的情况下不符合RCAB条件的患者,非急诊术中外周膜氧合作为部分心肺支持的新用途.
未经证实:45名高危患者(平均年龄,68岁;胸外科医师协会评分,6.27%;射血分数,45%)接受了非紧急外周体外膜氧合支持的RCAB,用于以下适应症:无法耐受单肺通气(n=17;38%),低射血分数<35%(n=17;38%),胸廓内动脉暴露不足(n=24;53%),严重冠状动脉疾病(n=16;36%),麻醉诱导后血流动力学不稳定(n=3;7%)。在机器人取下胸廓内动脉后,所有患者均通过2英寸小切口进行心脏跳动微创直接CAB.
未经批准:最长30天,没有中风(0%),心肌梗塞(0%),或进入血管并发症(0%)。1例非心脏相关死亡率(2.2%)与先前存在的终末期肾病患者的血液透析通路问题有关。一名redo-CAB(2.2%)患者需要胸骨切开术来定位目标血管。34例(75.6%)患者在手术后6小时内拔管。
UNASSIGNED:我们的结果研究了在RCAB期间使用外周体外膜氧合治疗高危患者的可行性,否则他们的选择有限。在RCAB中使用外周体外膜氧合可以潜在地扩展高危冠心病患者的手术治疗选择。
UNASSIGNED: Robot-assisted coronary artery bypass (RCAB) is typically not offered to higher risk patients with reduced cardiopulmonary function, critical coronary artery disease, and challenging chest wall anatomy. In this study, we report the novel use of nonemergency intraoperative peripheral extracorporeal membrane oxygenation as partial cardiopulmonary support during RCAB for patients who were considered high-risk candidates for conventional CAB and at the same time not eligible for RCAB without cardiopulmonary support.
UNASSIGNED: Forty-five high risk patients (mean age, 68 years; Society of Thoracic Surgeons score, 6.27%; ejection fraction, 45%) underwent RCAB with nonemergency peripheral extracorporeal membrane oxygenation support for the following indications: inability to tolerate single-lung ventilation (n = 17; 38%), low ejection fraction <35% (n = 17; 38%), inadequate exposure of internal thoracic artery (n = 24; 53%), critical coronary artery disease (n = 16; 36%), and hemodynamic instability after anesthesia induction (n = 3; 7%). Following robotic internal thoracic artery takedown, all patients had beating heart minimally invasive direct CAB through a 2-inch minithoracotomy.
UNASSIGNED: Up to 30 days, there were no strokes (0%), myocardial infarctions (0%), or access vessel complications (0%). One noncardiac related mortality (2.2%) was related to hemodialysis access issues in a patient with preexisting end-stage renal disease. One redo-CAB (2.2%) patient required sternotomy to locate the target vessel. Thirty-four (75.6%) patients were extubated within 6 hours of surgery.
UNASSIGNED: Our results examine the feasibility of using peripheral extracorporeal membrane oxygenation during RCAB for high-risk patients who otherwise had limited options. The use of peripheral extracorporeal membrane oxygenation in RCAB can potentially expand the surgical treatment options in high-risk coronary artery disease patients.